Furoscix in Heart Failure Patients With Diuretic Resistance

计划入组 70 人 · 首次发布于 2022 年 9 月 6 日

Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure

计划入组 27 人 · 首次发布于 2018 年 3 月 8 日

Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot Study

计划入组 63 人 · 首次发布于 2020 年 10 月 20 日

Furosemide(Furoscix, Lasix)

C₁₂H₁₁ClN₂O₅S · Rx

scPharmaceuticals

United States

FDA Approves MannKind's Furoscix ReadyFlow, the First Autoinjector for IV-Equivalent Diuretic Therapy in Heart Failure and CKD

FDA Accepts MannKind's ReadyFlow Autoinjector Application for Rapid Furosemide Delivery in Heart Failure

MannKind Acquires scPharmaceuticals for Up to $360M to Expand Cardiorenal Portfolio